Original Research

Published on 25 Jul 2023

T cell intrinsic STAT1 signaling prevents aberrant Th1 responses during acute toxoplasmosis

in Cytokines and Soluble Mediators in Immunity

Aaron B. Schultz
David G. Kugler
Luis Nivelo
Nicolas Vitari
Laura P. Doyle
Svetlana Ristin
Lothar Hennighausen
John J. O’Shea
Dragana Jankovic
Alejandro V. Villarino

Frontiers in Immunology

doi 10.3389/fimmu.2023.1212190

2,658 views
2 citations

Original Research

Published on 24 Jul 2023

GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity

in Cytokines and Soluble Mediators in Immunity

Serena Melgrati
Oliver J. Gerken
Marc Artinger
Egle Radice
Martyna Szpakowska
Andy Chevigné
Giulia D’Uonnolo
Paola Antonello
Sylvia Thelen
Pawel Pelczar

Frontiers in Immunology

doi 10.3389/fimmu.2023.1242531

3,980 views
4 citations

Original Research

Published on 24 Jul 2023

Immune-checkpoint proteins, cytokines, and microbiome impact on patients with cervical insufficiency and preterm birth

in Cytokines and Soluble Mediators in Immunity

Seri Jeong
Won Kyong Cho
Yeonhwa Jo
Soo-Ran Choi
Nuri Lee
Kibum Jeon
Min-Jeong Park
Wonkeun Song
Keun-Young Lee

Frontiers in Immunology

doi 10.3389/fimmu.2023.1228647

2,988 views
1 citation

Review

Published on 19 Jul 2023

Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells

in Cytokines and Soluble Mediators in Immunity

Qiuyun Yi
Jinxian Yang
Ying Wu
Ying Wang
Qiqi Cao
Wen Wen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1204524

3,535 views
2 citations

Editorial

Published on 14 Jul 2023

Editorial: Type 1 interferon in pathologies, autoimmune diseases, and chronic viral infections: understanding the fascinating biologic role of type 1 interferons

in Cytokines and Soluble Mediators in Immunity

Jean-Philippe Herbeuval

Frontiers in Immunology

doi 10.3389/fimmu.2023.1239086

1,611 views
1 citation

Review

Published on 14 Jul 2023

Mechanisms and applications of adipose-derived stem cell-extracellular vesicles in the inflammation of wound healing

in Cytokines and Soluble Mediators in Immunity

Qingyi Jia
Hanxing Zhao
Yixi Wang
Ying Cen
Zhenyu Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1214757

4,331 views
11 citations

Original Research

Published on 14 Jul 2023

Circulatory HMGB1 is an early predictive and prognostic biomarker of ARDS and mortality in a swine model of polytrauma

in Cytokines and Soluble Mediators in Immunity

Matthew D. Young
Tomas S. Cancio
Catherine R. Thorpe
Robert P. Willis
John K. Snook
Bryan S. Jordan
Samandra T. Demons
Jose Salinas
Zhangsheng Yang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1227751

2,580 views
3 citations

Original Research

Published on 13 Jul 2023

Cytokine profile characterization of naïve patients with psoriasis and psoriatic arthritis: implications for a pathogenic disease continuum

in Cytokines and Soluble Mediators in Immunity

Piero Ruscitti
Maria Esposito
Ilenia Di Cola
Cristina Pellegrini
Andrea De Berardinis
Mirco Mastrangelo
Camilla Gianneramo
Antonio Barile
Maria Concetta Fargnoli
Paola Cipriani

Frontiers in Immunology

doi 10.3389/fimmu.2023.1229516

2,792 views
6 citations

Original Research

Published on 06 Jul 2023

Identification and characterisation of anti-IL-13 inhibitory single domain antibodies provides new insights into receptor selectivity and attractive opportunities for drug discovery

in Cytokines and Soluble Mediators in Immunity

Kayleigh Walker
Roberta Baravalle
Rachel Holyfield
Jacqueline Kalms
Helena Wright
Chitra Seewooruthun
Frederick W. Muskett
Anthony Scott-Tucker
Andy Merritt
Alistair Henry

Frontiers in Immunology

doi 10.3389/fimmu.2023.1216967

3,145 views

Review

Published on 06 Jul 2023

Engineering cytokines for cancer immunotherapy: a systematic review

in Cytokines and Soluble Mediators in Immunity

Yong Fu
Renhong Tang
Xiaofeng Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1218082

12,757 views
13 citations

Original Research

Published on 05 Jul 2023

Growth hormone remodels the 3D-structure of the mitochondria of inflammatory macrophages and promotes metabolic reprogramming

in Cytokines and Soluble Mediators in Immunity

Blanca Soler Palacios
Ricardo Villares
Pilar Lucas
José Miguel Rodríguez-Frade
Ana Cayuela
Jonathan G. Piccirillo
Manuel Lombardía
David Delgado Gestoso
Miguel Fernández-García
Cristina Risco

Frontiers in Immunology

doi 10.3389/fimmu.2023.1200259

3,442 views
1 citation

Original Research

Published on 03 Jul 2023

Immunologic and vascular biomarkers of mortality in critical COVID-19 in a South African cohort

in Cytokines and Soluble Mediators in Immunity

Jane Alexandra Shaw
Maynard Meiring
Candice Snyders
Frans Everson
Lovemore Nyasha Sigwadhi
Veranyay Ngah
Gerard Tromp
Brian Allwood
Coenraad F. N. Koegelenberg
Elvis M. Irusen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1219097

2,950 views
2 citations

Review

Published on 30 Jun 2023

Emerging roles of a chemoattractant receptor GPR15 and ligands in pathophysiology

in Cytokines and Soluble Mediators in Immunity

Yukari Okamoto
Sojin Shikano

Frontiers in Immunology

doi 10.3389/fimmu.2023.1179456

4,256 views
2 citations

Original Research

Published on 28 Jun 2023

Macrophage IL-1β contributes to tumorigenesis through paracrine AIM2 inflammasome activation in the tumor microenvironment

in Cytokines and Soluble Mediators in Immunity

Zhi Huan Chew
Jianzhou Cui
Karishma Sachaphibulkij
Isabelle Tan
Shreya Kar
Kai Kiat Koh
Kritika Singh
Hong Meng Lim
Soo Chin Lee
Alan Prem Kumar

Frontiers in Immunology

doi 10.3389/fimmu.2023.1211730

4,022 views
4 citations

Review

Published on 22 Jun 2023

Intrathymic somatotropic circuitry: consequences upon thymus involution

in Cytokines and Soluble Mediators in Immunity

Maria Danielma dos Santos Reis
Luciana Peixoto Veneziani
Felipe Lima Porto
Marvin Paulo Lins
Daniella Arêas Mendes-da-Cruz
Wilson Savino

Frontiers in Immunology

doi 10.3389/fimmu.2023.1108630

3,795 views
4 citations

Original Research

Published on 20 Jun 2023

KL-6 levels in the connective tissue disease population: typical values and potential confounders–a retrospective, real-world study

in Cytokines and Soluble Mediators in Immunity

Aiyuan Zhou
Haiyun Tang
Wenzhong Peng
Yanan Wang
Xiaoping Tang
Hang Yang
Rongli Lu
Pinhua Pan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1098602

3,044 views
6 citations

Navigation group

Articles

T cell intrinsic STAT1 signaling prevents aberrant Th1 responses during acute toxoplasmosis

GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity

Immune-checkpoint proteins, cytokines, and microbiome impact on patients with cervical insufficiency and preterm birth

Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells

Editorial: Type 1 interferon in pathologies, autoimmune diseases, and chronic viral infections: understanding the fascinating biologic role of type 1 interferons

Mechanisms and applications of adipose-derived stem cell-extracellular vesicles in the inflammation of wound healing

Circulatory HMGB1 is an early predictive and prognostic biomarker of ARDS and mortality in a swine model of polytrauma

Cytokine profile characterization of naïve patients with psoriasis and psoriatic arthritis: implications for a pathogenic disease continuum

Identification and characterisation of anti-IL-13 inhibitory single domain antibodies provides new insights into receptor selectivity and attractive opportunities for drug discovery

Engineering cytokines for cancer immunotherapy: a systematic review

Growth hormone remodels the 3D-structure of the mitochondria of inflammatory macrophages and promotes metabolic reprogramming

Immunologic and vascular biomarkers of mortality in critical COVID-19 in a South African cohort

Emerging roles of a chemoattractant receptor GPR15 and ligands in pathophysiology

Macrophage IL-1β contributes to tumorigenesis through paracrine AIM2 inflammasome activation in the tumor microenvironment

Intrathymic somatotropic circuitry: consequences upon thymus involution

KL-6 levels in the connective tissue disease population: typical values and potential confounders–a retrospective, real-world study